This content is intended for informational purposes only and has been reviewed by Dr. Arnaud, Ph.D. in Pharmacy. This article is in no way a substitute for individualized medical advice. Any medication treatment requires a prescription and follow-up by a healthcare professional. If you are experiencing psychological distress, severe anxiety, persistent insomnia, or suicidal thoughts, speak with your primary care physician or call 3114 (the national suicide prevention hotline; toll-free, 24 hours a day). Sources: HAS, ANSM, Inserm.
“Sedatives” refer to a diverse group of substances used to relieve anxiety, tension, or agitation. This group includes both prescription medications and plants traditionally used in herbal medicine. Their selection, use, and duration of use must be supervised by a healthcare professional due to a significant risk of side effects, drug interactions, and dependence for certain classes of these substances.
The term “sedative” is generic: it refers to any substance capable of reducing anxiety, nervous tension, or agitation by inducing a state of relaxation. From a pharmacological standpoint, these substances act on the central nervous system by modulating the activity of neurotransmitters (GABA, serotonin, and norepinephrine, depending on the class). Benzodiazepines, for example, potentiate the effect of GABA, an inhibitory neurotransmitter, which produces a sedative and anxiolytic effect. The term “sedative,” however, is too broad to guide a therapeutic decision: only a medical evaluation can identify the most appropriate treatment for a given situation.
There are several categories, each with very different indications, mechanisms of action, and precautions:
Antipsychotics are not a common treatment option for anxiety in the general population: they are reserved for specific psychiatric indications and require a specialized prescription.
You should not self-prescribe a sedative: the choice depends on the type and severity of symptoms, medical history, other current treatments, and any potential contraindications. For mild, temporary anxiety, non-pharmacological approaches (lifestyle changes, stress management, psychological support, and traditional herbal remedies) are the first-line treatment of choice. For diagnosed anxiety disorders, depressive disorders, or severe insomnia, the primary care physician or psychiatrist determines the appropriate treatment strategy.
Adverse effects vary greatly depending on the class:
Any significant adverse effect should be reported to a doctor or pharmacist and may be reported to the national pharmacovigilance system.
Dependence is a recognized risk associated with the prolonged use of benzodiazepines and certain related drugs (Z-drugs). It manifests as tolerance (the need for higher doses to achieve the same effect), difficulty in discontinuing treatment, and withdrawal syndrome upon abrupt discontinuation. To minimize this risk, ANSM guidelines recommend short prescription durations (maximum 4 to 12 weeks depending on the indication, 2 to 4 weeks for insomnia, including a reassessment period). In cases of confirmed dependence, discontinuation must be gradual and supervised by a physician; it should never be abrupt. Complementary approaches (CBT, psychotherapeutic support, lifestyle changes) are useful in supporting the tapering-off process.
So-called “natural” sedatives include plants traditionally used for their calming effects (lemon balm, valerian, chamomile, passionflower, lavender, orange blossom), available in various forms (herbal teas, capsules, ampoules, mother tinctures). Their effects are generally milder, and individual tolerance may vary; however, they are not without risks (drug interactions, potential hepatotoxicity with valerian, and sensitization with certain plants). Prescription medications (benzodiazepines, antidepressants, hydroxyzine) have documented and reproducible efficacy, but are associated with more pronounced side effects and precautions. The choice between these approaches depends on the clinical context and should be discussed with the treating physician.
For acuteinsomnia, certain benzodiazepines or Z-drugs may be prescribed for a deliberately short duration (2 to 4 weeks maximum, according to ANSM recommendations), due to the risk of dependence and disruption of the natural sleep architecture. For chronic insomnia, the HAS and Inserm recommend **cognitive-behavioral therapy for insomnia (CBT-I)** as a first-line treatment, which has demonstrated long-term effectiveness without the adverse effects associated with medication. Good deep sleep hygiene (regular sleep schedules, exposure to natural light, limiting screen time in the evening, and physical activity during the day) provides a useful foundation.
Sedatives modulate central nervous system activity through various neurotransmitter systems:
The complexity of these mechanisms warrants individualized medical care and rules out any notion of self-medication.
Several precautions should always be taken:
Several non-pharmacological approaches are recognized for the management ofanxiety, either as a first-line treatment or as a complement to medical care:
These approaches are often part of a step-by-step process to be developed with your primary care physician or a mental health professional.
A medical consultation is necessary in cases of anxiety symptoms that persist or interfere with daily life, chronic insomnia, suicidal thoughts, or severe psychological distress. If you are having suicidal thoughts, call 3114 (the national suicide prevention hotline; toll-free, 24 hours a day) or go to the emergency room. In a life-threatening emergency, call 15 or 112.
References: French National Authority for Health (HAS)—recommendations on the management of insomnia and anxiety disorders; French National Agency for Medicines and Health Products Safety (ANSM)—prescription durations for benzodiazepines; National Institute of Health and Medical Research (Inserm)—resource pages on anxiety and sleep.